pathology

Ibex Medical Analytics raises $38M for its AI-powered cancer diagnostic platform

Israel-based Ibex Medical Analytics, which has an AI-driven imaging technology to detect cancer cells in biopsies more efficiently, has raised a $38 million Series B financing round led by Octopus Ven

3M and MIT partner to develop a new, affordable rapid COVID-19 test

A heavyweight partnership between industry and academic sciences is throwing their considerable weight into an important task: creating a new low-cost, rapid diagnostic test for COVID-19. Chemical ind

Paige, the computational pathology startup targeting cancer, closes a Series B at $70M

Paige, the startup that spun out of the Memorial Sloan Kettering Cancer Center and launched in 2018 to help advance cancer research and care by applying AI to better understand cancer pathology, is to

Paige adds $5M from Goldman Sachs to double down on AI-based cancer therapies

Paige, the Sloan-Kettering spinout that has been building an artificial intelligence platform to improve cancer pathology and subsequently use those insights to develop better drug therapies, has rais

Paige raises $45M more to map the pathology of cancer using AI

One of the more notable startups using artificial intelligence to understand and fight cancer has raised $45 million more in funding to continue building out its operations and inch closer to commerci

Paige details first AI pathology tech with clinical-grade accuracy in new research paper

Researchers associated with Memorial Sloan Kettering Cancer Center and medical tech and computational pathology startup Paige have published a new article in the peer-reviewed medical journal Nature M

Matternet’s autonomous delivery drones can now refuel and reload by themselves

Matternet, a startup building autonomous drones for delivery, has been working to commercialize its tech via transportation of blood and pathology samples to labs. Taking traffic out of the equation

GE and the Mayo Clinic back software to bring cancer-fighting gene therapies to market

While $5.7 billion was invested in companies developing cellular and genetic therapies, and with 800 clinical trials initiated worldwide and the first two CAR-T cell therapies expected to launch into

FishTaco can analyze your microbiome before or after you eat a fish taco

Our microbiomes: who understands them? Scientists? The bacteria colonizing our guts? The guy who made the Mexican food we just ate? Wrong. It’s our computers. Researchers have tasked them to cre

3Scan raises $14 million for a robotic microscope that could accelerate drug discovery

Robots and software aren’t just changing manual labor in warehouses or kitchens. They’re also transforming medical research. A San Francisco startup called 3Scan Inc. raised $14 million in venture